Efficacy and safety of denosumab for the treatment of osteoporosis in patients with renal failure

Trial Profile

Efficacy and safety of denosumab for the treatment of osteoporosis in patients with renal failure

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Denosumab (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2017 Status changed from completed to recruiting.
    • 10 Oct 2016 Status changed from recruiting to completed.
    • 14 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top